Assertio (ASRT) stock closed 8% higher Monday after the company refuted allegations leveled by Buxton Helmsley over its accounting practices and drug Rolvedon. Read more here.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback